In The News
Stay up to date with Dr. Quay
Atossa Therapeutics Seeks Clinical Investigation Approval from FDA to Launch the COVID-19 HOPE Study
The COVID-19 HOPE trial is the first pharmaceutical study to address getting patients off mechanical ventilator and reducing
COVID-19 “Cease Fire” for the United States on April 23, 2020 and successful ‘Opening Up America Again’ initiative predicted
U.S. Physician Scientist Dr. Steven Quay, MD, PhD offers his predictions based on COVID-19 case growth model and firsthand eye witness to Taiwan’s coronavirus best practice policies, many of which are mirrored in the U.S. Administration’s policies
“I will be attending this workshop on COVID-19 diagnostic testing and will provide a blog if there is something new and relevant”,: said Dr. Steven Quay, MD, PhD. Please stay tuned here.